RSC Advances
Paper
result in the formation of the product 3m and 3o respectively.
Interestingly, the re-insertion of the palladium on to the
product was not observed under the reaction conditions. Hence
the formation of the product with endocyclic double bond was
not found.
orally efficacious RORgt inverse agonists. part 2: design,
synthesis,
and
biological
evaluation
of
novel
tetrahydroisoquinoline derivatives, Bioorg. Med. Chem.,
2018, 26, 470–482; (g) M. Kairuki, Q. Qiu, M. Pan, Q. Li,
J. Zhou, H. Ghaleb, W. Huang, H. Qian and C. Jiang,
Designed
P-glycoprotein
inhibitors
with
triazol-
tetrahydroisoquinoline-core increase doxorubicin-induced
mortality in multidrug resistant K562/A02 cells, Bioorg.
Med. Chem., 2019, 27, 3347–3357; (h) Y. S. Li, X. Y. Liu,
D. S. Zhao, Y. X. Liao, L. H. Zhang, F. Z. Zhang, G. P. Song
Conclusion
In conclusion, we have developed an intramolecular sequential
carbopalladation and cyclization methodology for the synthesis
of highly biologically relevant C4-substituted tetrahy-
droisoquinoline analogues. The prime advantages of this
transformation are being the exclusive formation of (Z)-exo
olen group containing tetrahydroisoquinoline derivatives. The
possibility for the generation tetrahydroisoquinolines with all
carbon quaternary stereogenic centers at C4 carbon atom is also
demonstrated.
and
Z.
N.
Cui,
Tetrahydroquinoline
and
tetrahydroisoquinoline derivatives as potential selective
PDE4B inhibitors, Bioorg. Med. Chem. Lett., 2018, 28, 3271–
3275; (i) H. Watanabe, K. Fukui, Y. Shimizu, Y. Idoko,
Y. Nakamoto, K. Togashi, H. Saji and M. Ono, Synthesis
and
biological
evaluation
of
F-18
labeled
tetrahydroisoquinoline derivatives targeting orexin
1
receptor, Bioorg. Med. Chem. Lett., 2019, 29, 1620–1623.
2
3
I. P. Singh and P. Shah, Tetrahydroisoquinolines in
therapeutics: a patent review (2010–2015), Expert Opin.
Ther. Pat., 2017, 27, 17–36 and references cited therein.
Z. L. Zhao, Q. L. Xu, Q. Gu, X. Y. Wu and S. L. You,
Conflicts of interest
There are no conicts to declare.
Enantioselective
tetrahydroisoquinolines
synthesis
via
of
4-substituted
Acknowledgements
palladium-catalyzed
Financial support from the Council of Scientic and Industrial
Research, CSIR (80(0085)/16/EMR-II) is gratefully acknowledged
by S. S. G. The authors thank the SASTRA Deemed University for
providing lab space and the NMR facility. We thank Director,
CSIR-IICT for the support (IICT/Pubs./2019/315).
intramolecular Friedel–Cras type allylic alkylation of
phenols, Org. Biomol. Chem., 2015, 13, 3086–3092 and
references cited therein.
4 X. Deng, J. T. Liang, J. Liu, H. McAllister, C. Schubert and
N. S. Mani, A practical synthesis of enantiopure 7-alkoxy-4-
aryl-tetrahydroisoquinoline,
inhibitor/histamine H antagonist, Org. Process Res. Dev.,
007, 11, 1043–1050.
a dual serotonin reuptake
3
References
2
1
(a) J. D. Scott and R. M. Williams, Chemistry and biology of
the tetrahydroisoquinoline antitumor antibiotics, Chem.
Rev., 2002, 102, 1669–1730; (b) S. M. Devine, C. Yong,
D. Amenuvegbe, L. Aurelio, D. Muthaih, C. Pouton,
R. Callaghan, B. Capuano and P. J. Scammells, Synthesis
and pharmacological evaluation of noscapine-inspired 5-
substituted tetrahydroisoquinolines as cytotoxic agents, J.
Med. Chem., 2018, 61, 8444–8456; (c) N. Oku, S. Matsunaga,
R. W. M. Vansoest and N. Fusetani, Renieramycin J,
a highly cytotoxic tetrahydroisoquinoline alkaloid, from
a marine sponge neopetrosia sp., J. Nat. Prod., 2003, 66,
5 M. Kihara, M. Ikeuchi, A. Yamauchi, M. Nukatsuka,
H. Matsumoto and T. Toko, Synthesis and biological
evaluation
dihydroisoquinolines
of
7-hydroxy-3,4-diphenyl-1,2-
new 4-hydroxytamoxifen
as
analogues, Chem. Pharm. Bull., 1997, 45, 939–943.
6 A. Brossi, G. Grethe, S. Teitel, W. C. Wildman and D. T. Bailey,
Cherylline, a 4-phenyl-1,2,3,4-tetrahydroisoquinoline alkaloid,
J. Org. Chem., 1970, 35, 1100–1104.
7 (a) X. Vidal, J. L. Mascarenas and M. Gulias, Palladium-
catalyzed, enantioselective formal cycloaddition between
benzyltriamides and allenes: straightforward access to
enantioenriched isoquinolines, J. Am. Chem. Soc., 2019,
141, 1862–1866; (b) S. Nakamura, M. Tanaka, T. Taniguchi,
M. Uchiyama and T. Ohwada, Stereoselectivity of
superacid-catalyzed Pictet-Spengler cyclization reactions,
Org. Lett., 2003, 5, 2087–2090; (c) Y. Hu, Y. Xie, Z. Shen and
1136–1139; (d) Y. Fang, H. Zhou, Q. Gu and J. Xu,
Synthesis and evaluation of tetrahydroisoquinoline–
benzimidazole hybrids as multifunctional agents for the
treatment of Alzheimer's disease, Eur. J. Med. Chem., 2019,
1
67, 133–145; (e) A. S. Capilla, R. Soucek, L. Grau,
M. Romero, J. R. Martnez, D. H. Caignard and M. D. Pujol,
Substituted tetrahydroisoquinolines: synthesis,
H.
Huang,
Palladium-catalyzed
ring-forming
aminoalkenylation of alkenes with aldehydes initiated by
intramolecular aminopalladation, Angew. Chem., Int. Ed.,
2017, 56, 2473–2477; (d) A. Nandakumar, D. Muralidharan
and P. T. Perumal, Synthesis of functionalized
tetrahydroisoquinolines via palladium-catalyzed 6-exo-dig
carbocyclization of 2-bromo-N-propargylbenzylamines,
Tetrahedron Lett., 2011, 52, 1644–1648.
characterization, antitumor activity and other biological
properties, Eur. J. Med. Chem., 2018, 145, 51–63; (f)
M. Kono, T. Oda, M. Tawada, T. Imada, Y. Banno, N. Taya,
T. Kawamoto, H. Tokuhara, Y. Tomata, N. Ishii, A. Ochida,
Y. Fukase, T. Yukawa, S. Fukumoto, H. Watanabe, K. Uga,
A. Shibata, H. Nakagawa, M. Shirasaki, Y. Fujitani,
M. Yamasaki, J. Shirai and S. Yamamoto, Discovery of
15798 | RSC Adv., 2020, 10, 15794–15799
This journal is © The Royal Society of Chemistry 2020